MACOM Reports Revised GAAP Loss Per Share of $0.15 for its Fiscal Second Quarter; Non-GAAP EPS of $0.41 Unchanged
In
This non-cash, non-operating charge did not affect MACOM's previously
reported non-GAAP earnings per share of
About MACOM
Headquartered in
MACOM, M/
Special Note Regarding Forward-Looking Statements
This press release contains forward-looking statements based on MACOM management's beliefs and assumptions and on information currently available to our management. Forward-looking statements include, among others, information concerning our stated business outlook and future results of operations, our statements regarding having the right strategy, addressing the right secular growth drivers, with the correct technology, intellectual property and leadership team to assure long term success, and any statements regarding future trends, business strategies, competitive position, industry conditions, acquisitions and market opportunities. Forward-looking statements include all statements that are not historical facts and generally may be identified by terms such as "anticipates," "believes," "could," "estimates," "expects," "intends," "may," "plans," "potential," "predicts," "projects," "seeks," "should," "will," "would" or similar expressions and the negatives of those terms.
Forward-looking statements contained in this press release reflect
MACOM's current views about future events and are subject to risks,
uncertainties, assumptions and changes in circumstances that may cause
those events or our actual activities or results to differ materially
from those expressed in any forward-looking statement. Although MACOM
believes that the expectations reflected in the forward-looking
statements are reasonable, it cannot and does not guarantee future
events, results, actions, levels of activity, performance or
achievements. Readers are cautioned not to place undue reliance on these
forward-looking statements. A number of important factors could cause
actual results to differ materially from those indicated by the
forward-looking statements, including greater than expected dilutive
effect on earnings of our equity issuances, outstanding indebtedness and
related interest expense and other costs, lower than expected demand in
any or all of our four primary end markets or from any of our large OEM
customers based on seasonal effects, macro-economic weakness or
otherwise, our failure to realize the expected economies of scale,
lowered production cost and other anticipated benefits of our previously
announced GaN intellectual property licensing program or InP laser
production capacity expansion program, the potential for defense
spending cuts, program delays, cancellations or sequestration, failures
or delays by any customer in winning business or to make purchases from
us in support of such business, lack of adoption or delayed adoption by
customers and industries we serve of GaN, InP lasers or other solutions
offered by us, failures or delays in porting and qualifying GaN or InP
process technology to our
Non-GAAP Financial Measures
In addition to GAAP reporting, MACOM provides investors with non-GAAP financial information, including revenue, gross margin, operating margin, operating income, net income, earnings per share, EBITDA and other data calculated on a non-GAAP basis. This non-GAAP information excludes the operations of Nitronex prior to the date of acquisition, discontinued operations, the impact of fair value accounting in merger and acquisitions (M&A) of businesses, M&A costs, including acquisition and related integration costs, certain cost savings from synergies expected from M&A activities, income and expenses from transition services related to M&A activities, expected amortization of acquisition-related intangibles, share-based and other non-cash compensation expense, certain cash compensation, restructuring charges, litigation settlement and costs, changes in the carrying values of assets and liabilities measured at fair value, contingent consideration, amortization of debt discounts and issuance costs, other non-cash expenses, earn-out costs, exited leased facility costs and certain income tax items. Management does not believe that the excluded items are reflective of MACOM's underlying performance. The exclusion of these and other similar items from MACOM's non-GAAP presentation should not be interpreted as implying that these items are non-recurring, infrequent or unusual. These and other similar items are also excluded from EBITDA, which is non-GAAP earnings before interest, income taxes, depreciation and amortization. MACOM believes this non-GAAP financial information provides additional insight into MACOM's on-going performance and has, therefore, chosen to provide this information to investors for a consistent basis of comparison and to help them evaluate the results of MACOM's on-going operations and enable more meaningful period to period comparisons. These non-GAAP measures are provided in addition to, and not as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. A reconciliation between GAAP and non-GAAP financial data is included in the supplemental financial data attached to this press release.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited and in thousands, except per share data) |
||||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||
2015 |
2015 |
2014 |
2015 |
2014 |
||||||||||||||||||||||||||
(Revised) | (Revised) | |||||||||||||||||||||||||||||
Revenue | $ | 124,885 | $ | 114,864 | $ | 107,827 | $ | 239,749 | $ | 191,981 | ||||||||||||||||||||
Cost of revenue | 70,878 | 60,663 | 80,964 | 131,541 |
129,396 |
|||||||||||||||||||||||||
Gross profit | 54,007 | 54,201 | 26,863 | 108,208 | 62,585 | |||||||||||||||||||||||||
Operating expenses: | ||||||||||||||||||||||||||||||
Research and development | 21,061 | 19,474 | 20,347 | 40,535 | 32,777 | |||||||||||||||||||||||||
Selling, general and administrative | 29,227 | 25,599 | 24,504 | 54,826 | 43,887 | |||||||||||||||||||||||||
Restructuring charges | 413 | — | 2,635 | 413 | 15,725 | |||||||||||||||||||||||||
Total operating expenses | 50,701 | 45,073 | 47,486 | 95,774 | 92,389 | |||||||||||||||||||||||||
Income (loss) from operations | 3,306 | 9,128 | (20,623 | ) | 12,434 | (29,804 | ) | |||||||||||||||||||||||
Other income (expense): | ||||||||||||||||||||||||||||||
Warrant liability expense | (5,609 | ) | (10,608 | ) | (4,066 | ) | (16,217 | ) | (2,784 | ) | ||||||||||||||||||||
Interest expense | (4,723 | ) | (4,723 | ) | (1,622 | ) | (9,446 | ) | (2,208 | ) | ||||||||||||||||||||
Other income (expense) | (1,376 | ) | 375 | 1,009 | (1,001 | ) | 1,087 | |||||||||||||||||||||||
Total other expense | (11,708 | ) | (14,956 | ) | (4,679 | ) | (26,664 | ) | (3,905 | ) | ||||||||||||||||||||
Loss before income taxes | (8,402 | ) | (5,828 | ) | (25,302 | ) | (14,230 | ) | (33,709 | ) | ||||||||||||||||||||
Income tax provision (benefit) | (865 | ) | 478 | (5,680 | ) | (387 | ) | (7,271 | ) | |||||||||||||||||||||
Loss from continuing operations | (7,537 | ) | (6,306 | ) | (19,622 | ) | (13,843 | ) | (26,438 | ) | ||||||||||||||||||||
Loss from discontinued operations | — | — | (2,500 | ) | — | (4,605 | ) | |||||||||||||||||||||||
Net loss | $ | (7,537 | ) | $ | (6,306 | ) | $ | (22,122 | ) | $ | (13,843 | ) | $ | (31,043 | ) | |||||||||||||||
Net loss per share: | ||||||||||||||||||||||||||||||
Basic: | ||||||||||||||||||||||||||||||
Loss from continuing operations | $ | (0.15 | ) | $ | (0.13 | ) | $ | (0.42 | ) | $ | (0.28 | ) | $ | (0.57 | ) | |||||||||||||||
Loss from discontinued operations | — | — | (0.05 | ) | — | (0.10 | ) | |||||||||||||||||||||||
Loss per share - basic | $ | (0.15 | ) | $ | (0.13 | ) | $ | (0.47 | ) | $ | (0.28 | ) | $ | (0.67 | ) | |||||||||||||||
Diluted: | ||||||||||||||||||||||||||||||
Loss from continuing operations | $ | (0.15 | ) | $ | (0.13 | ) | $ | (0.42 | ) | $ | (0.28 | ) | $ | (0.57 | ) | |||||||||||||||
Loss from discontinued operations | — | — | (0.05 | ) | — | (0.10 | ) | |||||||||||||||||||||||
Loss per share - diluted | $ | (0.15 | ) | $ | (0.13 | ) | $ | (0.47 | ) | $ | (0.28 | ) | $ | (0.67 | ) | |||||||||||||||
Shares: | ||||||||||||||||||||||||||||||
Basic | 50,593 | 47,606 | 46,808 | 49,100 | 46,656 | |||||||||||||||||||||||||
Diluted | 50,593 | 47,606 | 46,808 | 49,100 | 46,656 | |||||||||||||||||||||||||
RECONCILIATION OF GAAP TO NON-GAAP RESULTS (unaudited and in thousands, except per share data) |
|||||||||||||||||||||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||||||
(Revised) | |||||||||||||||||||||||||||||||||||||||
Amount | Amount | Amount | |||||||||||||||||||||||||||||||||||||
Revenue - GAAP |
|
$ | 114,864 | $ | 107,827 | ||||||||||||||||||||||||||||||||||
Nitronex prior to acquisition | — | — | (362 | ) | |||||||||||||||||||||||||||||||||||
Revenue - Non-GAAP |
|
$ | 114,864 | $ | 107,465 | ||||||||||||||||||||||||||||||||||
Amount |
% |
Amount |
% |
Amount |
% |
||||||||||||||||||||||||||||||||||
Gross Profit - GAAP | $ | 54,007 | 43.2 | % | $ | 54,201 | 47.2 | % | $ | 26,863 | 24.9 | % | |||||||||||||||||||||||||||
Nitronex prior to acquisition | — | — | — | — | 16 | 0.1 | |||||||||||||||||||||||||||||||||
Amortization expense | 7,347 | 5.9 | 5,359 | 4.7 | 6,262 | 5.8 | |||||||||||||||||||||||||||||||||
Non-cash compensation expense | 599 | 0.5 | 354 | 0.3 | 426 | 0.4 | |||||||||||||||||||||||||||||||||
Equity-based compensation | 179 | 0.1 | 58 | 0.1 | 30 | — | |||||||||||||||||||||||||||||||||
Acquisition FMV step-up | 3,538 | 2.8 | 835 | 0.7 | 18,003 | 16.8 | |||||||||||||||||||||||||||||||||
Third-party engineering costs | 305 | 0.2 | 924 | 0.8 | 570 | 0.5 | |||||||||||||||||||||||||||||||||
Integration costs and synergy savings | 356 | 0.3 | (4 | ) | — | 822 | 0.8 | ||||||||||||||||||||||||||||||||
Gross Profit - non-GAAP | $ | 66,331 | 53.1 | % | $ | 61,727 | 53.7 | % | $ | 52,992 | 49.3 | % | |||||||||||||||||||||||||||
Research and Development - GAAP | $ | 21,061 | 16.9 | % | $ | 19,474 | 17.0 | % | $ | 20,347 | 18.9 | % | |||||||||||||||||||||||||||
Nitronex prior to acquisition | — | — | — | — | (438 | ) | (0.5 | ) | |||||||||||||||||||||||||||||||
Non-cash compensation expense | (1,620 | ) | (1.3 | ) | (1,038 | ) | (0.9 | ) | (728 | ) | (0.7 | ) | |||||||||||||||||||||||||||
Equity-based compensation | (669 | ) | (0.5 | ) | (519 | ) | (0.5 | ) | (137 | ) | (0.1 | ) | |||||||||||||||||||||||||||
Acquisition FMV step-up | (204 | ) | (0.2 | ) | (204 | ) | (0.2 | ) | (183 | ) | (0.2 | ) | |||||||||||||||||||||||||||
Integration costs and synergy savings | (137 | ) | (0.1 | ) | (171 | ) | (0.1 | ) | (2,414 | ) | (2.2 | ) | |||||||||||||||||||||||||||
Third-party engineering costs | 305 | 0.2 | 924 | 0.8 | 570 | 0.5 | |||||||||||||||||||||||||||||||||
Research and Development - non-GAAP | $ | 18,736 | 15.0 | % | $ | 18,466 | 16.1 | % | $ | 17,017 | 15.8 | % | |||||||||||||||||||||||||||
Selling, General and Administrative - GAAP | $ | 29,227 | 23.4 | % | $ | 25,599 | 22.3 | % | $ | 24,504 | 22.7 | % | |||||||||||||||||||||||||||
Nitronex prior to acquisition | — | — | — | — | (191 | ) | (0.4 | ) | |||||||||||||||||||||||||||||||
Amortization expense | (3,096 | ) | (2.5 | ) | (1,053 | ) | (0.9 | ) | (476 | ) | (0.4 | ) | |||||||||||||||||||||||||||
Non-cash compensation expense | (7,578 | ) | (6.1 | ) | (2,405 | ) | (2.1 | ) | (2,136 | ) | (2.0 | ) | |||||||||||||||||||||||||||
Equity-based compensation | (501 | ) | (0.4 | ) | (317 | ) | (0.3 | ) | (214 | ) | (0.2 | ) | |||||||||||||||||||||||||||
Acquisition FMV step-up | (28 | ) | — | (28 | ) | — | (21 | ) | — | ||||||||||||||||||||||||||||||
Litigation costs | (971 | ) | (0.8 | ) | (717 | ) | (0.6 | ) | (440 | ) | (0.4 | ) | |||||||||||||||||||||||||||
Transaction expenses | 530 | 0.4 | (4,636 | ) | (4.0 | ) | (250 | ) | (0.2 | ) | |||||||||||||||||||||||||||||
Integration costs and synergy savings | (282 | ) | (0.2 | ) | (296 | ) | (0.3 | ) | (6,178 | ) | (5.4 | ) | |||||||||||||||||||||||||||
Selling, General and Administrative - non-GAAP | $ | 17,301 | 13.9 | % | $ | 16,147 | 14.1 | % | $ | 14,598 | 13.6 | % | |||||||||||||||||||||||||||
Total operating expenses - GAAP | $ | 50,701 | 40.6 | % | $ | 45,073 | 39.2 | % | $ | 47,486 | 44.0 | % | |||||||||||||||||||||||||||
Nitronex prior to acquisition | — | — | — | — | (629 | ) | (0.6 | ) | |||||||||||||||||||||||||||||||
Amortization expense | (3,096 | ) | (2.5 | ) | (1,053 | ) | (0.9 | ) | (476 | ) | (0.4 | ) | |||||||||||||||||||||||||||
Non-cash compensation expense | (9,198 | ) | (7.4 | ) | (3,443 | ) | (3.0 | ) | (2,864 | ) | (2.7 | ) | |||||||||||||||||||||||||||
Equity-based compensation | (1,170 | ) | (0.9 | ) | (836 | ) | (0.7 | ) | (351 | ) | (0.3 | ) | |||||||||||||||||||||||||||
Acquisition FMV step-up | (232 | ) | (0.2 | ) | (232 | ) | (0.2 | ) | (204 | ) | (0.2 | ) | |||||||||||||||||||||||||||
Restructuring charges | (413 | ) | (0.3 | ) | — | — | (2,635 | ) | (2.5 | ) | |||||||||||||||||||||||||||||
Integration costs and synergy savings | (419 | ) | (0.3 | ) | (467 | ) | (0.4 | ) | (8,592 | ) | (8.0 | ) | |||||||||||||||||||||||||||
Litigation costs | (971 | ) | (0.8 | ) | (717 | ) | (0.6 | ) | (440 | ) | (0.4 | ) | |||||||||||||||||||||||||||
Transaction expenses | 530 | 0.4 | (4,636 | ) | (4.0 | ) | (250 | ) | (0.2 | ) | |||||||||||||||||||||||||||||
Third-party engineering |
305 | 0.2 | 924 | 0.8 | 570 | 0.5 | |||||||||||||||||||||||||||||||||
Total operating expenses - non-GAAP | $ | 36,037 | 28.9 | % | $ | 34,613 | 30.1 | % | $ | 31,615 | 29.4 | % | |||||||||||||||||||||||||||
Income (loss) from operations - GAAP | $ | 3,306 | 2.6 | % | $ | 9,128 | 7.9 | % | $ | (20,623 | ) | (19.1 | ) | % | |||||||||||||||||||||||||
Nitronex prior to acquisition | — | — | — | — | 645 | 0.8 | |||||||||||||||||||||||||||||||||
Amortization expense | 10,446 | 8.4 | 6,412 | 5.6 | 6,738 | 6.3 | |||||||||||||||||||||||||||||||||
Non-cash compensation expense | 9,797 | 7.8 | 3,797 | 3.3 | 3,290 | 3.1 | |||||||||||||||||||||||||||||||||
Equity-based compensation | 1,349 | 1.1 | 894 | 0.8 | 381 | 0.4 | |||||||||||||||||||||||||||||||||
Restructuring charges | 413 | 0.3 | — | — | 2,635 | 2.5 | |||||||||||||||||||||||||||||||||
Acquisition FMV step-up | 3,770 | 3.0 | 1,067 | 0.8 | 18,207 | 16.9 | |||||||||||||||||||||||||||||||||
Litigation costs | 971 | 0.8 | 717 | 0.6 | 440 | 0.4 | |||||||||||||||||||||||||||||||||
Transaction expenses | (530 | ) | (0.4 | ) | 4,636 | 4.0 | 250 | 0.2 | |||||||||||||||||||||||||||||||
Integration costs and synergy savings | 772 | 0.6 | 463 | 0.6 | 9,414 | 8.8 | |||||||||||||||||||||||||||||||||
Income from operations - non-GAAP | $ | 30,294 | 24.3 | % | $ | 27,114 | 23.6 | % | $ | 21,377 | 19.9 | % | |||||||||||||||||||||||||||
Net loss - GAAP | $ | (7,537 | ) | (6.0 | ) | % | $ | (6,306 | ) | (5.5 | ) | % | $ | (22,122 | ) | (20.5 | ) | % | |||||||||||||||||||||
Nitronex prior to acquisition | — | — | — | — | 645 | 0.6 | |||||||||||||||||||||||||||||||||
Amortization expense | 8,566 | 6.9 | 5,258 | 4.6 | 5,155 | 4.8 | |||||||||||||||||||||||||||||||||
Non-cash compensation expense | 8,309 | 6.7 | 3,113 | 2.7 | 2,517 | 2.3 | |||||||||||||||||||||||||||||||||
Equity-based compensation | 1,107 | 0.9 | 733 | 0.6 | 291 | 0.3 | |||||||||||||||||||||||||||||||||
Impairment of minority investment | 2,230 | 1.8 | — | — | — | — | |||||||||||||||||||||||||||||||||
Contingent consideration | (1,640 | ) | (1.3 | ) | — | — | — | — | |||||||||||||||||||||||||||||||
Restructuring charges | 339 | 0.3 | — | — | 2,016 | 1.9 | |||||||||||||||||||||||||||||||||
Warrant liability expense | 5,609 | 4.5 | 10,608 | 9.2 | 4,066 | 3.8 | |||||||||||||||||||||||||||||||||
Non-cash interest expense | 330 | 0.3 | 360 | 0.3 | 91 | 0.1 | |||||||||||||||||||||||||||||||||
Acquisition FMV step-up | 3,092 | 2.5 | 875 | 0.8 | 13,061 | 12.2 | |||||||||||||||||||||||||||||||||
Litigation costs | 797 | 0.6 | 588 | 0.5 | 337 | 0.3 | |||||||||||||||||||||||||||||||||
Integration costs and synergy savings | 633 | 0.5 | 380 | 0.3 | 7,201 | 6.7 | |||||||||||||||||||||||||||||||||
Transaction expenses | (435 | ) | (0.3 | ) | 3,420 | 3.0 | 191 | 0.2 | |||||||||||||||||||||||||||||||
Transition services for divested business | (102 | ) | (0.1 | ) | (308 | ) | (0.3 | ) | (741 | ) | (0.7 | ) | |||||||||||||||||||||||||||
Discontinued operations | — | — | — | — | 2,500 | 2.3 | |||||||||||||||||||||||||||||||||
Net income - non-GAAP | $ | 21,298 | 17.1 | % | $ | 18,721 | 16.3 | % | $ | 15,208 | 14.2 | % | |||||||||||||||||||||||||||
Income from operations - non-GAAP | $ | 30,294 | $ | 27,114 | $ | 21,377 | |||||||||||||||||||||||||||||||||
Depreciation expense | 3,759 | 3,453 | 3,367 | ||||||||||||||||||||||||||||||||||||
Other income, net | — | — | 40 | ||||||||||||||||||||||||||||||||||||
EBITDA | $ | 34,053 | $ | 30,567 | $ | 24,784 | |||||||||||||||||||||||||||||||||
Interest expense- GAAP | $ | 4,723 | $ | 4,723 | $ | 1,622 | |||||||||||||||||||||||||||||||||
Non-cash interest expense | (403 | ) | (439 | ) | (119 | ) | |||||||||||||||||||||||||||||||||
Interest expense- non-GAAP | $ | 4,320 | $ | 4,284 | $ | 1,503 | |||||||||||||||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||||||
(Revised) | |||||||||||||||||||||||||||||||||||||||
Amount |
Income |
Amount |
Income |
Amount |
Income |
||||||||||||||||||||||||||||||||||
Net loss - GAAP | $ | (7,537 | ) | $ | (0.15 | ) | $ | (6,306 | ) | $ | (0.13 | ) | $ | (22,122 | ) | $ | (0.47 | ) | |||||||||||||||||||||
Net income - non-GAAP | $ | 21,298 | $ | 0.41 | $ | 18,721 | $ | 0.38 | $ | 15,208 | $ | 0.32 | |||||||||||||||||||||||||||
Diluted shares - GAAP | 50,593 | 47,606 | 46,808 | ||||||||||||||||||||||||||||||||||||
Incremental stock options, warrants, |
1,908 | 1,599 | 1,406 | ||||||||||||||||||||||||||||||||||||
Diluted shares - non-GAAP | 52,501 | 49,206 | 48,214 | ||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
RECONCILIATION OF GAAP TO NON-GAAP RESULTS (unaudited and in thousands, except per share data) |
||||||||||||||||||||||||||||
Six Months Ended | ||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||
(Revised) | ||||||||||||||||||||||||||||
Amount | Amount | |||||||||||||||||||||||||||
Revenue - GAAP | $ | 239,749 | $ | 191,981 | ||||||||||||||||||||||||
Nitronex prior to acquisition | — | (1,048 | ) | |||||||||||||||||||||||||
Revenue - non-GAAP | $ | 239,749 | $ | 190,933 | ||||||||||||||||||||||||
Amount |
% |
Amount |
% |
|||||||||||||||||||||||||
Gross Profit - GAAP | $ | 108,208 | 45.1 | % | $ | 62,585 | 32.6 | % | ||||||||||||||||||||
Nitronex prior to acquisition | — | — | 959 | 0.5 | ||||||||||||||||||||||||
Amortization expense | 12,706 | 5.3 | 7,509 | 3.9 | ||||||||||||||||||||||||
Non-cash compensation expense | 953 | 0.4 | 709 | 0.4 | ||||||||||||||||||||||||
Equity-based compensation | 237 | 0.1 | 30 | — | ||||||||||||||||||||||||
Acquisition FMV step-up | 4,373 | 1.8 | 18,539 | 9.7 | ||||||||||||||||||||||||
Integration costs and synergy savings | 352 | 0.1 | 961 | 0.5 | ||||||||||||||||||||||||
Third-party engineering costs | 1,229 | 0.5 | 570 | 0.3 | ||||||||||||||||||||||||
Gross Profit - non-GAAP |
|
53.4 | % |
|
48.1 | % | ||||||||||||||||||||||
Research and Development - GAAP |
|
16.9 | % |
|
17.1 | % | ||||||||||||||||||||||
Nitronex prior to acquisition | — | — | (1,423 | ) | (0.8 | ) | ||||||||||||||||||||||
Non-cash compensation expense | (2,658 | ) | (1.1 | ) | (1,212 | ) | (0.6 | ) | ||||||||||||||||||||
Equity-based compensation | (1,188 | ) | (0.5 | ) | (137 | ) | (0.1 | ) | ||||||||||||||||||||
Acquisition FMV step-up | (408 | ) | (0.2 | ) | (255 | ) | (0.1 | ) | ||||||||||||||||||||
Integration costs and synergy savings | (308 | ) | (0.1 | ) | (2,450 | ) | (1.3 | ) | ||||||||||||||||||||
Third-party engineering costs | 1,229 | 0.5 | 570 | 0.3 | ||||||||||||||||||||||||
Research and Development - non-GAAP | $ | 37,202 | 15.5 | % |
|
14.6 | % | |||||||||||||||||||||
Selling, General and Administrative - GAAP |
|
22.9 | % |
|
22.9 | % | ||||||||||||||||||||||
Nitronex prior to acquisition | — | — | (685 | ) | (0.5 | ) | ||||||||||||||||||||||
Amortization expense | (4,149 | ) | (1.7 | ) | (842 | ) | (0.4 | ) | ||||||||||||||||||||
Non-cash compensation expense | (9,983 | ) | (4.2 | ) | (3,214 | ) | (1.7 | ) | ||||||||||||||||||||
Equity-based compensation | (818 | ) | (0.3 | ) | (214 | ) | (0.1 | ) | ||||||||||||||||||||
Acquisition FMV step-up | (56 | ) | — | (32 | ) | — | ||||||||||||||||||||||
Integration costs and synergy savings | (578 | ) | (0.2 | ) | (6,593 | ) | (3.5 | ) | ||||||||||||||||||||
Litigation costs | (1,688 | ) | (0.7 | ) | (1,404 | ) | (0.7 | ) | ||||||||||||||||||||
Transaction expenses | (4,106 | ) | (1.7 | ) | (4,472 | ) | (2.3 | ) | ||||||||||||||||||||
Selling, General and Administrative - non-GAAP |
|
14.0 | % |
|
13.8 | % | ||||||||||||||||||||||
Total operating expenses - GAAP |
|
39.9 | % |
|
48.1 | % | ||||||||||||||||||||||
Nitronex prior to acquisition | — | — | (2,108 | ) | (1.2 | ) | ||||||||||||||||||||||
Amortization expense | (4,149 | ) | (1.7 | ) | (842 | ) | (0.4 | ) | ||||||||||||||||||||
Non-cash compensation expense | (12,641 | ) | (5.3 | ) | (4,426 | ) | (2.3 | ) | ||||||||||||||||||||
Equity-based compensation | (2,006 | ) | (0.8 | ) | (351 | ) | (0.2 | ) | ||||||||||||||||||||
Acquisition FMV step-up | (464 | ) | (0.2 | ) | (287 | ) | (0.2 | ) | ||||||||||||||||||||
Contingent consideration and earn-out costs | — | — | — | — | ||||||||||||||||||||||||
Restructuring charges | (413 | ) | (0.2 | ) | (15,725 | ) | (8.2 | ) | ||||||||||||||||||||
Integration costs and synergy savings | (886 | ) | (0.4 | ) | (9,043 | ) | (4.7 | ) | ||||||||||||||||||||
Litigation costs | (1,688 | ) | (0.7 | ) | (1,404 | ) | (0.7 | ) | ||||||||||||||||||||
Transaction expenses | (4,106 | ) | (1.7 | ) | (4,472 | ) | (2.3 | ) | ||||||||||||||||||||
Third-party engineering | 1,229 | 0.5 | 570 | 0.3 | ||||||||||||||||||||||||
Total operating expenses - non-GAAP |
|
29.5 | % |
|
28.4 | % | ||||||||||||||||||||||
Income (loss) from operations - GAAP |
|
5.2 | % | (29,804 | ) | (15.5 | ) | % | ||||||||||||||||||||
Nitronex prior to Acquisition | — | — | 3,067 | 1.8 | ||||||||||||||||||||||||
Amortization expense | 16,858 | 7.0 | 8,351 | 4.4 | ||||||||||||||||||||||||
Non-cash compensation expense | 13,594 | 5.7 | 5,135 | 2.7 | ||||||||||||||||||||||||
Equity-based compensation | 2,243 | 0.9 | 381 | 0.2 | ||||||||||||||||||||||||
Contingent consideration and earn-out costs | — | — | — | — | ||||||||||||||||||||||||
Restructuring charges | 413 | 0.2 | 15,725 | 8.2 | ||||||||||||||||||||||||
Acquisition FMV step-up | 4,837 | 2.0 | 18,826 | 9.9 | ||||||||||||||||||||||||
Integration costs and synergy savings | 1,235 | 0.5 | 10,004 | 5.2 | ||||||||||||||||||||||||
Litigation costs | 1,688 | 0.7 | 1,404 | 0.7 | ||||||||||||||||||||||||
Transaction expenses | 4,106 | 1.7 | 4,472 | 2.3 | ||||||||||||||||||||||||
Income from operations - non-GAAP |
|
23.9 | % |
|
19.7 | % | ||||||||||||||||||||||
Net loss - GAAP | $(13,843 | ) | (5.8 | ) | % | $(31,043 | ) | (16.2 | ) | % | ||||||||||||||||||
Nitronex prior to acquisition | — | — | 3,067 | 1.2 | ||||||||||||||||||||||||
Amortization expense | 13,824 | 5.8 | 6,389 | 3.3 | ||||||||||||||||||||||||
Non-cash compensation expense | 11,148 | 4.6 | 3,928 | 2.1 | ||||||||||||||||||||||||
Equity-based compensation | 1,840 | 0.8 | 291 | 0.2 | ||||||||||||||||||||||||
Impairment of minority investment | 2,230 | 0.9 | — | — | ||||||||||||||||||||||||
Contingent consideration | (1,640 | ) | (0.7 | ) | — | — | ||||||||||||||||||||||
Restructuring charges | 339 | 0.1 | 12,030 | 6.3 | ||||||||||||||||||||||||
Warrant liability expense | 16,217 | 6.8 | 2,784 | 1.5 | ||||||||||||||||||||||||
Non-cash interest expense | 689 | 0.3 | 182 | 0.1 | ||||||||||||||||||||||||
Acquisition FMV step-up | 3,966 | 1.7 | 13,535 | 7.1 | ||||||||||||||||||||||||
Integration costs and synergy savings | 1,012 | 0.4 | 7,652 | 4.0 | ||||||||||||||||||||||||
Litigation costs | 1,385 | 0.6 | 1,074 | 0.6 | ||||||||||||||||||||||||
Transaction expenses | 3,261 | 1.4 | 3,537 | 1.9 | ||||||||||||||||||||||||
Transition services for divested business | (409 | ) | (0.2 | ) | (741 | ) | (0.4 | ) | ||||||||||||||||||||
Discontinued operations | — | — | 4,605 | 2.4 | ||||||||||||||||||||||||
Net income - non-GAAP |
|
16.7 | % |
|
14.3 | % | ||||||||||||||||||||||
Amount |
Income |
Amount |
Income |
|||||||||||||||||||||||||
Net loss - GAAP | $ | (13,843 | ) | $ | (0.28 | ) | $(31,043 | ) | $(0.67 | ) | ||||||||||||||||||
Net income - non-GAAP |
|
|
|
|
||||||||||||||||||||||||
Diluted shares - GAAP | 49,100 | 46,656 | ||||||||||||||||||||||||||
Incremental stock options, warrants, restricted |
1,814 | 1,412 | ||||||||||||||||||||||||||
Diluted shares - non-GAAP | 50,914 | 48,068 | ||||||||||||||||||||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited and in thousands) |
|||||||||||
|
|
||||||||||
2015 | 2014 | ||||||||||
(Revised) | |||||||||||
ASSETS | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 73,970 | $ | 173,895 | |||||||
Accounts receivable, net | 89,350 | 75,156 | |||||||||
Inventories | 84,077 | 73,572 | |||||||||
Deferred income taxes and other | 61,343 | 50,726 | |||||||||
Total current assets | 308,740 | 373,349 | |||||||||
Property and equipment, net | 65,352 | 50,357 | |||||||||
Goodwill and intangible assets, net | 357,900 | 153,417 | |||||||||
Deferred income taxes and other | 68,257 | 105,111 | |||||||||
TOTAL ASSETS | $ | 800,249 | $ | 682,234 | |||||||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||
Current liabilities: | |||||||||||
Current portion of long-term debt | $ | 4,062 | $ | 3,478 | |||||||
Accounts payable, accrued liabilities and other | 63,844 | 64,910 | |||||||||
Deferred revenue | 267 | 17,258 | |||||||||
Total current liabilities | 68,173 | 85,646 | |||||||||
Long-term debt, less current portion | 342,335 | 343,178 | |||||||||
Common stock warrant liability | 32,018 | 15,801 | |||||||||
Deferred income taxes and other | 8,028 | 9,042 | |||||||||
Total liabilities | 450,554 | 453,667 | |||||||||
Commitments and contingencies | |||||||||||
Stockholders' equity | 349,695 | 228,567 | |||||||||
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ | 800,249 | $ | 682,234 | |||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited and in thousands) |
||||||||||||
Six Months Ended | ||||||||||||
|
|
|||||||||||
2015 | 2014 | |||||||||||
(Revised) | ||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||||||
Net loss | $ | (13,843 | ) | $ | (31,043 | ) | ||||||
Non-cash adjustments | 57,481 | 43,029 | ||||||||||
Change in operating assets and liabilities | (27,620 | ) | (16,270 | ) | ||||||||
Net cash from operating activities | 16,018 | (4,284 | ) | |||||||||
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||||||
Acquisition of businesses, net | (222,955 | ) | (258,108 | ) | ||||||||
Sale of a business | — | 8,627 | ||||||||||
Strategic investments | (250 | ) | — | |||||||||
Purchases of property and equipment | (14,036 | ) | (5,994 | ) | ||||||||
Acquisition of intellectual property | (1,587 | ) | (4,096 | ) | ||||||||
Net cash used in investing activities | (238,828 | ) | (259,571 | ) | ||||||||
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||||||
Proceeds from issuance of term notes payable | — | 245,000 | ||||||||||
Payment of debt | (2,982 | ) | (34,952 | ) | ||||||||
Capital contributions | — | 3,200 | ||||||||||
Proceeds from stock offering, net | 127,959 | — | ||||||||||
Proceeds from revolving credit facility | 100,000 | — | ||||||||||
Payments on revolving credit facility | (100,000 | ) | — | |||||||||
Financing activities | (2,092 | ) | 3,258 | |||||||||
Net cash from financing activities | 122,885 | 216,506 | ||||||||||
NET CHANGE IN CASH AND CASH EQUIVALENTS | (99,925 | ) | (47,349 | ) | ||||||||
CASH AND CASH EQUIVALENTS — Beginning of period | 173,895 | 110,488 | ||||||||||
CASH AND CASH EQUIVALENTS — End of period | $ | 73,970 | $ | 63,139 | ||||||||
Company Contact:
Senior Vice President and Chief Financial
Officer
bob.mcmullan@macom.com
or
Investor
Relations Contact:
EVP, Investor Relations
lsievers@sheltongroup.com
Source: MACOM
News Provided by Acquire Media